Possible Case Report of Furosemide-Induced Psoriasis
Journal Title: Journal of Pharmaceutics & Pharmacology - Year 2015, Vol 3, Issue 2
Abstract
Purpose: After reviewing PubMed, drug-induced psoriasis has been previously reported. This case is believed to be the first furosemide-induced psoriasis reported and includes a summarization of antihypertensive-induced psoriasis on some of the previously published literature. Summary: A 32-year-old African American female with hypertension secondary to edema was noted to have developed psoriasis 3.3 years after the initiation of furosemide 20 mg orally once daily. She initially had a new-onset rash to hydrochlorothiazide 25 mg orally once daily after 1 week prior to switching to furosemide. After presenting with her psoriatic-like skin lesions all throughout her body while on furosemide for 3.3 years, dermatologic biopsy confirmed the psoriasis diagnosis. After discontinuation of furosemide and initiation of topical and oral supportive medications, the patient’s psoriasis resolved after 4 weeks. She was changed to lisinopril 10 mg orally once daily then finally switched to losartan 50 mg orally once daily with spironolactone 50 mg orally twice daily. Conclusion: Using the scale of Naranjo et al. it was determined that furosemide use was the possible cause of the patient’s psoriasis. This report can contribute to the literature by describing another druginduced psoriasis and provide a possible first case report of furosemideinduced psoriasis.
Authors and Affiliations
Jennifer Clements
Keywords
Related Articles
- EP ID EP198083
- DOI 10.13188/2327-204X.1000016
- Views 111
- Downloads 0
Reactive Oxygen Species as β2-Adrenergic Receptor Signal Transducers
Reactive oxygen species (ROS), which include superoxide (O2−), hydrogen peroxide (H2O2), and the hydroxyl radical (OH.), have traditionally been cast as cellular byproducts, having benefit only for their microbicidal pro...
A Case of Suspected Drug Interaction Between Topiramate and Co-administered Clarithromycin/Pranlukast
Case description: A 4-year-old boy presented with tuberous sclerosis and symptomatic partial epilepsy of the upper right extremity. Topiramate was prescribed for the treatment of epilepsy, and seizure behavior was well c...
Development of Controlled- Release Solid Dispersion Granules Containing a Poorly Water-Soluble Drug, Porous Calcium Silicate, and the Water-Soluble Polymer Polyvinylpyrrolidone
Objectives: This study sought to develop controlled-release solid dispersion granules containing a poorly water-soluble drug, porous calcium silicate (PCS), and a water-soluble polymer. Methods: Nifedipine (NIF) and ind...
Mathematical Model of Pharmacokinetic Behavior of Orally Administered Prednisolone in Healthy Volunteers
The objective of the current study was to develop mathematical models that described the pharmacokinetic behavior of prednisolone in healthy subjects after the oral administration of prednisolone. The current study is a...
Invitro and Invivo Inhibition of Metyraponemetabolism by Glycyrrhetinic Acid in Male Wistar Rats
Objectives: We investigated the inhibitory effect of glycyrrhetinic acid (GA), an 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor, on the reductive metabolism of metyrapone (MP) in an invitro study, and the...